Fault diagnosis and economic performance evaluation for a simulated base metal leaching operation von Strydom, Johannes Jacobus, Miskin, Jason John, McCoy, John Themba, Auret, Lidia, Dorfling, Christie

Volltext

The Use of a Semi-Rigorous SAG Mill Model for a Hands-On Workshop von Bauer, Margret, Brooks, Kevin, Burchell, John, Coetzee, Loutjie, Roux, Derik le, McCoy, John, Miskin, Jason, Winter, Danielle

Volltext

Fault detection for simulated valve faults in a high pressure leaching process von Miskin, Jason, Lindner, Brian, Auret, Lidia, Dorfling, Christie, Bradshaw, Steven

Volltext

Particle shape effects on the stress response of granular packings von Athanassiadis, Athanasios G, Miskin, Marc Z, Kaplan, Paul, Rodenberg, Nicholas, Lee, Seung Hwan, Merritt, Jason, Brown, Eric, Amend, John, Lipson, Hod, Jaeger, Heinrich M

Volltext

Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, ra... von Sharman, Jeff P, Brander, Danielle M, Mato, Anthony R, Ghosh, Nilanjan, Schuster, Stephen J, Kambhampati, Suman, Burke, John M, Lansigan, Frederick, Schreeder, Marshall T, Lunin, Scott D, Zweibach, Alexander, Shtivelband, Mikhail, Travis, Patrick M, Chandler, Jason C, Kolibaba, Kathryn S, Sportelli, Peter, Miskin, Hari P, Weiss, Michael S, Flinn, Ian W

Volltext

Efficacy and Safety of Umbralisib, Ublituximab (U2), and U2 Plus Bendamustine in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) von Burke, John M., Fonseca, Gustavo, Jurczak, Wojciech, Melear, Jason, Islas-Ohlmayer, Miguel, Reeves, James A, Venugopal, Parameswaran, Wróbel, Tomasz, Stevens, Don, Pagel, John M., Goldschmidt, Jerome, Miskin, Hari P., Sportelli, Peter, O'Connor, Owen A., Ghosh, Nilanjan

Volltext

Effect of adding ublituximab to ibrutinib on PFS, ORR, and MRD negativity in previously treated high-risk chronic lymphocytic leukemia: Final results of the GENUINE phase III study von Sharman, Jeff P., Brander, Danielle M., Mato, Anthony R., Ghosh, Nilanjan, Schuster, Stephen J., Kambhampati, Suman, Burke, John M., Lansigan, Frederick, Schreeder, Marshall T., Lunin, Scott D, Zweibach, Alexander, Shtivelband, Mikhail, Travis, Patrick M., Chandler, Jason Claud, Kolibaba, Kathryn S., Sportelli, Peter, Miskin, Hari P., Weiss, Michael S., Flinn, Ian

Volltext

Ublituximab and ibrutinib for previously treated genetically high-risk chronic lymphocytic leukemia: Results of the GENUINE phase 3 study von Sharman, Jeff Porter, Brander, Danielle M., Mato, Anthony R., Kambhampati, Suman, Burke, John M., Lansigan, Frederick, Schreeder, Marshall T., Lunin, Scott D., Ghosh, Nilanjan, Zweibach, Alexander, Shtivelband, Mikhail, Travis, Patrick M., Chandler, Jason Claud, Kolibaba, Kathryn S., Sportelli, Peter, Miskin, Hari P., Weiss, Michael S., Flinn, Ian

Volltext

Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory Mantle Cell... von Kolibaba, Kathryn, Burke, John M., Brooks, Heather D., Mahadevan, Daruka, Melear, Jason, Farber, Charles M., Fanning, Suzanne R., Schreeder, Marshall T., Boccia, Ralph V., Sportelli, Peter, Miskin, Hari P., Weiss, Michael S., Sharman, Jeff P.

Volltext

Particle Shape Effects on the Stress Response of Granular Packings von Athanassiadis, Athanasios G, Miskin, Marc Z, Kaplan, Paul, Rodenberg, Nicholas, Lee, Seung Hwan, Merritt, Jason, Brown, Eric, Amend, John, Lipson, Hod, Jaeger, Heinrich M

Volltext